buparlisib codenamed experimental anticancer medication small molecule orallyavailable panclass phosphoinositide buparlisib investigation treatment advanced breast cancer abandoned due negative results still investigation potential treatment head neck squamous cell carcinoma hnscc buparlisib investigation treatment advanced metastatic breast cancer several phase iii clinical trials results led trials sponsor novartis cancel breast cancer study program buparlisib buparlisib still investigation potential treatment head neck squamous cell carcinoma hnscc ongoing phase iii trial buran compares buparlisib paclitaxel paclitaxel alone patients recurrent metastatic hnscc results expected december antineoplastic immunomodulatory drug article stub help wikipedia expanding httpsenwikipediaorgwikibuparlisib